Adamax, a laboratory-made peptide sold online for memory and focus, has never been given to a person or an animal. Claims about it are borrowed from its parent peptide, Semax, or inferred from its chemistry; Semax’s modest evidence comes almost entirely from one Russian research network, mostly in ill people. Unmeasured hazards include signs of bleeding risk in rats, immune reaction risk from injected peptides, and unreliable product labels. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Platelet count | 150–450 × 10⁹/L | Bleeding safety check |
| aPTT | 25–35 seconds | Clotting-time safety check |
| Seated blood pressure | Below 120/80 mmHg | Safety check for raised blood pressure |
| Resting heart rate | No established target; change from own pre-use baseline | Safety check for palpitations and raised heart rate |
Cadence: Baseline before starting; about 2 weeks after starting, at the end of a 4-week cycle, then before each subsequent cycle; immediate retesting if bruising, bleeding, palpitations or persistent headache appear